Cargando…

Correction: Re-Examination of 30-Day Survival and Relapse Rates in Patients with Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome

Detalles Bibliográficos
Autores principales:	Bittencourt, Cassiana E., Ha, Jennifer P., Maitta, Robert W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476808/ https://www.ncbi.nlm.nih.gov/pubmed/26098743 http://dx.doi.org/10.1371/journal.pone.0131384

Ejemplares similares

Re-Examination of 30-Day Survival and Relapse Rates in Patients with Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome
por: Bittencourt, Cassiana E., et al.
Publicado: (2015)

Clopidogrel-Induced Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome After Coronary Artery Stenting
por: Manor, Shawn M, et al.
Publicado: (2004)

Post-Transfusion Simultaneous Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome: A Rare Occurrence
por: Patel, Maharshi, et al.
Publicado: (2022)

Thrombotic Thrombocytopenic Purpura-Haemolytic Uremic Syndrome and pregnancy
por: Mwita, Julius Chacha, et al.
Publicado: (2014)

Anti‐CD20 therapeutic options in immune‐mediated thrombotic thrombocytopenic purpura
por: Maitta, Robert W.
Publicado: (2022)

Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a
por: Ben-Amor, Ali-Frédéric, et al.
Publicado: (2015)

Urine Protein/Creatinine Ratio in Thrombotic Microangiopathies: A Simple Test to Facilitate Thrombotic Thrombocytopenic Purpura and Hemolytic and Uremic Syndrome Diagnosis
por: Burguet, Laure, et al.
Publicado: (2022)

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients
por: Levandovsky, Mark, et al.
Publicado: (2008)

Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018)

Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023)

Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine
por: Sissa, Cinzia, et al.
Publicado: (2021)

Thrombotic Thrombocytopenic Purpura and Gemcitabine
por: Kasi, Pashtoon Murtaza
Publicado: (2011)

Dengue and Thrombotic Thrombocytopenic Purpura
por: Wiwanitkit, Viroj
Publicado: (2017)

Vaccination and Thrombotic Thrombocytopenic Purpura
por: Yavaşoğlu, İrfan
Publicado: (2020)

Caplacizumab for thrombotic thrombocytopenic purpura
Publicado: (2020)

Hereditary Thrombotic Thrombocytopenic Purpura
por: Nusrat, Sanober, et al.
Publicado: (2023)

Thrombotic Thrombocytopenic Purpura Without Evidence of Microangiopathic Hemolytic Anemia: A Case Report
por: Lakra, Rachaita, et al.
Publicado: (2023)

Tozinameran: Relapse of immune-mediated thrombotic thrombocytopenic purpura: case report
Publicado: (2022)

Thrombotic Thrombocytopenic Purpura Associated with Pazopanib
por: Syed, Umer, et al.
Publicado: (2018)

Novel therapies in thrombotic thrombocytopenic purpura
por: Masias, Camila, et al.
Publicado: (2017)

Thrombotic Thrombocytopenic Purpura Associated with Dermatomyositis
por: Malik, Zohra R, et al.
Publicado: (2018)

Cardiac implications of thrombotic thrombocytopenic purpura
por: Wiernek, Szymon L, et al.
Publicado: (2018)

Ticagrelor-associated thrombotic thrombocytopenic purpura
por: Doğan, Ali, et al.
Publicado: (2017)

Valacyclovir-Induced Thrombotic Thrombocytopenic Purpura
por: Bukhari, Sumera, et al.
Publicado: (2020)

Thrombotic thrombocytopenic purpura secondary to Streptococcus
por: Morrin, M.J., et al.
Publicado: (2006)

Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura
por: Arıkan, Fatma, et al.
Publicado: (2020)

Caplacizumab for Acute Thrombotic Thrombocytopenic Purpura
por: Katsivalis, Katherine V., et al.
Publicado: (2021)

Daratumumab for immune thrombotic thrombocytopenic purpura
por: van den Berg, Jana, et al.
Publicado: (2022)

mRNA-1273: Relapsed acquired thrombotic thrombocytopenic purpura: case report
Publicado: (2022)

Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura
por: Oh, Jisu, et al.
Publicado: (2019)

Opana-induced thrombotic microangiopathy masquerading as thrombotic thrombocytopenic purpura
por: Ban, Byung H., et al.
Publicado: (2017)

Interferon beta-1b-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) in a patient treated for multiple sclerosis: A case report
por: Etemadifar, Masoud, et al.
Publicado: (2018)

Coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an Asian woman: a case report
por: Ge, Hangping, et al.
Publicado: (2022)

Concurrence of immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura: a case report and review of the literature
por: Lin, Hung-Chen, et al.
Publicado: (2023)

Thrombotic thrombocytopenic purpura associated with cerebral SLE.
por: McHenry, M., et al.
Publicado: (2003)

Moxifloxacin (Avelox) Induced Thrombotic Thrombocytopenic Purpura
por: Surana, Sikander P., et al.
Publicado: (2012)

Thrombotic thrombocytopenic purpura in the first trimester of pregnancy
por: Sikka, Pooja, et al.
Publicado: (2013)

Management of thrombotic thrombocytopenic purpura: current perspectives
por: Blombery, Piers, et al.
Publicado: (2014)

Opana(®) ER induced thrombotic thrombocytopenic purpura
por: Kotbi, Nabil, et al.
Publicado: (2015)

Recombinant thrombomodulin for secondary thrombotic thrombocytopenic purpura
por: Nakamura, Kensuke, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cokhf2ijer7slnka3o1njqpdo0